Drug
ART-123
ART-123 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph phase_3
3
60%
Ph phase_2
1
20%
Ph phase_4
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
3(60.0%)
Phase 4Post-market surveillance
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Terminated(1)
Detailed Status
Completed4
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (20.0%)
Phase 33 (60.0%)
Phase 41 (20.0%)
Trials by Status
completed480%
withdrawn120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
NCT01598831
withdrawnphase_3
The Safety And Efficacy of ART-123 in Subjects With Sepsis and Coagulopathy
NCT03517501
completedphase_3
Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
NCT02739165
completedphase_4
Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment
NCT01704001
completedphase_2
Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation
NCT00487656
Clinical Trials (5)
Showing 5 of 5 trials
NCT01598831Phase 3
Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
NCT03517501Phase 3
The Safety And Efficacy of ART-123 in Subjects With Sepsis and Coagulopathy
NCT02739165Phase 3
Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
NCT01704001Phase 4
Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment
NCT00487656Phase 2
Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5